Financial Gravity Asset Management’s Integra LifeSciences IART Stock Holding History

Financial Gravity Asset Management’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-45	Closed	-$68K	–	974
2021 Q2	$68K	Buy	+45	New	+$3.18K	0.02%	468
2019 Q4	–	Sell	-300	Closed	-$18K	–	1535
2019 Q3	$18K	Buy	+300	New	+$17.9K	0.02%	477
2018 Q3	$49K	Buy	+791	New	+$49.2K	0.05%	329
2018 Q2	–	Sell	-175	Closed	-$11K	–	1500
2018 Q1	$11K	Buy	+175	New	+$9.17K	0.01%	576

Other funds holding IART

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

EVM

Eaton Vance Management Boston, Massachusetts $67.5B AUM 11.44% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Financial Gravity Asset Management's IART Position: Q3 2021 in Review

Financial Gravity Asset Management sold out of Integra LifeSciences (IART) in Q3 2021, closing a stake of 45 shares — an estimated $68K sold.

Financial Gravity Asset Management first reported a position in IART in Q1 2018 and held it in 4 quarters. The position peaked at $68K in Q2 2021. 261 funds tracked by Wall St. Rank hold IART as of Q3 2021.

Financial Gravity Asset Management reported no remaining Integra LifeSciences position as of Q3 2021 after selling out during the quarter.
Financial Gravity Asset Management sold 45 Integra LifeSciences shares in Q3 2021, an estimated $68K.
Financial Gravity Asset Management first reported a position in Integra LifeSciences in Q1 2018 and held it in 4 quarters.
Financial Gravity Asset Management's Integra LifeSciences position peaked at $68K in Q2 2021.
261 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2021.

Based on Financial Gravity Asset Management's 13F filing for Q3 2021, filed 12 Nov 2021.